The extracellular matrix modulates the hallmarks of cancer

EMBO Reports

Volumn 15, Issue 12, 2014, Pages 1243-1253

  Pickup, Michael W ^a   Mouw, Janna K ^a   Weaver, Valerie M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ECM; hallmarks of cancer; mechanotransduction

Indexed keywords

ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FOCAL ADHESION KINASE; HYALURONIDASE; PROTEIN BAX; PROTEIN BCL 2; RAF PROTEIN; SONIC HEDGEHOG PROTEIN;

ADAPTIVE IMMUNITY; ANGIOGENESIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL DEATH; CELL ENERGY; CELL INVASION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; ENZYME THERAPY; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; IMMUNOSURVEILLANCE; MALIGNANT TRANSFORMATION; METASTASIS; NEOPLASM; NONHUMAN; ONCOGENE; REVIEW; STROMA CELL; TELOMERE SHORTENING; TUMOR CELL; TUMOR GROWTH; BIOLOGICAL MODEL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

EXTRACELLULAR MATRIX; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84915763166     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.15252/embr.201439246     Document Type: Review

References (134)

1. Mammoto T, Ingber DE, (2010) Mechanical control of tissue and organ development. Development 137: 1407-1420
2. Leitinger B, Hohenester E, (2007) Mammalian collagen receptors. Matrix Biol 26: 146-155
3. Xian X, Gopal S, Couchman JR, (2010) Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res 339: 31-46
4. Hynes RO, (2009) The extracellular matrix: not just pretty fibrils. Science 326: 1216-1219
5. Egeblad M, Rasch MG, Weaver VM, (2010) Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 22: 697-706
6. Lu P, Weaver VM, Werb Z, (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196: 395-406
7. Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, White JG, Keely PJ, (2008) Collagen density promotes mammary tumor initiation and progression. BMC Med 6: 11
8. Leventhal KR, Yu H, Kass L, Lakin JN, Egebald M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, et al, (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891-906
9. Pandol S, Edderkaoui M, Gukovsky I, Lugea A, Gukovskaya A, (2009) Desmoplasia of pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol 7: S44-S47
10. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ, (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226
11. Slattery ML, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L, Giuliano A, Baumgartner K, Herrick J, Wolff RK, (2013) Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS One 8: e63165
12. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J, (1998) Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 28: 921-925
13. Neglia JP, FitzSimmons SC, Maisonneuve P, Schoni MH, Schoni-Affolter F, Corey M, Lowenfels AB, (1995) The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 332: 494-499
14. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, et al, (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356: 227-236
15. Boghaert E, Gleghorn JP, Lee K, Gjorevski N, Radisky DC, Nelson CM, (2012) Host epithelial geometry regulates breast cancer cell invasiveness. Proc Natl Acad Sci USA 109: 19632-19637
16. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70
17. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674
18. Weigelt B, Ghajar CM, Bissell MJ, (2014) The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv Drug Deliv Rev 69-70: 42-51
19. Schwartz MA, Assoian RK, (2001) Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J Cell Sci 114: 2553-2560
20. Xiong J, Balcioglu HE, Danen EH, (2013) Integrin signaling in control of tumor growth and progression. Int J Biochem Cell Biol 45: 1012-1015
21. Keely PJ, (2011) Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. J Mammary Gland Biol Neoplasia 16: 205-219
22. Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, Giancotti FG, (2009) Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 119: 252-266
23. Naba A, Clauser KR, Hoersch S, Liu H, Carr SA, Hynes RO, (2012) The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics 11: M111.014647
24. Zahir N, Weaver VM, (2004) Death in the third dimension: apoptosis regulation and tissue architecture. Curr Opin Genet Dev 14: 71-80
25. Naba A, Clauser KR, Lamar JM, Carr SA, Hynes RO, (2014) Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. Elife 3: e01308
26. Pattabiraman PP, Rao PV, (2010) Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells. Am J Physiol Cell Physiol 298: C749-C763
27. Tilghman RW, Cowan CR, Mih JD, Koryakina Y, Gioeli D, Slack-Davis JK, Blackman BR, Tschumperlin DJ, Parsons JT, (2010) Matrix rigidity regulates cancer cell growth and cellular phenotype. PLoS One 5: e12905
28. Folkman J, Moscona A, (1978) Role of cell shape in growth control. Nature 273: 345-349
29. Chen CS, (2008) Mechanotransduction-a field pulling together? J Cell Sci 121: 3285-3292
30. Schwartz MA, (2010) Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol 2: a005066
31. Wells RG, (2008) The role of matrix stiffness in regulating cell behavior. Hepatology 47: 1394-1400
32. Provenzano PP, Keely PJ, (2011) Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J Cell Sci 124: 1195-1205
33. Chambard JC, Lefloch R, Pouyssegur J, Lenormand P, (2007) ERK implication in cell cycle regulation. Biochim Biophys Acta 1773: 1299-1310
34. Bae YH, Mui KL, Hsu BY, Liu SL, Cretu A, Razinia Z, Xu T, Pure E, Assoian RK, (2014) A FAK-Cas-Rac-lamellipodin signaling module transduces extracellular matrix stiffness into mechanosensitive cell cycling. Sci Signal 7: ra57
35. Collins K, Jacks T, Pavletich NP, (1997) The cell cycle and cancer. Proc Natl Acad Sci USA 94: 2776-2778
36. Massague J, (2008) TGFbeta in Cancer. Cell 134: 215-230
37. Agarwal ML, Agarwal A, Taylor WR, Stark GR, (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92: 8493-8497
38. Lee KY, Bae SC, (2002) TGF-beta-dependent cell growth arrest and apoptosis. J Biochem Mol Biol 35: 47-53
39. Massague J, (2012) TGFbeta signalling in context. Nat Rev Mol Cell Biol 13: 616-630
40. Reinhardt HC, Schumacher B, (2012) The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet 28: 128-136
41. Gerard C, Goldbeter A, (2014) The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition. Interface Focus 4: 20130075
42. Kim W, Seok Kang Y, Soo Kim J, Shin NY, Hanks SK, Song WK, (2008) The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling. Mol Biol Cell 19: 2135-2146
43. O'Connell FC, Martin F, (2000) Laminin-rich extracellular matrix association with mammary epithelial cells suppresses Brca1 expression. Cell Death Differ 7: 360-367
44. Barkan D, Green JE, Chambers AF, (2010) Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer 46: 1181-1188
45. Shibue T, Weinberg RA, (2009) Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 106: 10290-10295
46. Pontier SM, Muller WJ, (2008) Integrins in breast cancer dormancy. APMIS 116: 677-684
47. Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L, (2003) ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 63: 1684-1695
48. Schrader J, Gordon-Walker TT, Aucott RL, van Deemter M, Quass A, Walsh S, Benten D, Forbes SJ, Wells RG, Iredale JP, (2011) Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology 53: 1192-1205
49. Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ, (2009) Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15: 35-44
50. Mouw JK, Yui Y, Damiano L, Bainer RO, Lakin JN, Acerbi I, Ou G, Wijekoon AC, Levental KR, Gilbert PM, et al, (2014) Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat Med 20: 360-367
51. Zhou B, Wei X, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, Zheng P, et al, (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761
52. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Condenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, et al, (2011) Role of YAP/TAZ in mechanotransduction. Nature 474: 179-183
53. Brown JM, Attardi LD, (2005) The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5: 231-237
54. Reginato MJ, Mills KR, Paulus JK, Lynch DK, Sgroi DC, Debnath J, Muthuswamy SK, Brugge JS, (2003) Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 5: 733-740
55. Ruoslahti E, Reed JC, (1994) Anchorage dependence, integrins, and apoptosis. Cell 77: 477-478
56. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY, (1996) Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134: 793-799
57. Gilmore AP, Metcalfe AD, Romer LH, Streuli CH, (2000) Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J Cell Biol 149: 431-446
58. Zahir N, Lakins JN, Russell A, Ming W, Chatterjee C, Rozenberg GI, Marinkovich MP, Weaver VM, (2003) Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 163: 1397-1407
59. Hayashi M, Yamamoto Y, Ibusuki M, Fujiwara S, Yamamoto S, Tomita S, Nakano M, Murakami K, Iyaka K, Iwase H, (2012) Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer. Ann Surg Oncol 19: 3042-3049
60. Lewis JM, Truong TN, Schwartz MA, (2002) Integrins regulate the apoptotic response to DNA damage through modulation of p53. Proc Natl Acad Sci USA 99: 3627-3632
61. Golubovskaya VM, Cance WG, (2011) FAK and p53 protein interactions. Anticancer Agents Med Chem 11: 617-619
62. Lim ST, Chen XL, Lim Y, Hanson DA, Vo TT, Howerton K, Larocque N, Fisher SJ, Schlaepfer DD, Ilic D, (2008) Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell 29: 9-22
63. Weaver VM, Lelievre S, Lakins JN, Chrenek MA, Jones JC, Giancotti F, Werb Z, Bissell MJ, (2002) beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2: 205-216
64. Yu ST, Chen L, Wang HJ, Tang XD, Fang DC, Yang SM, (2009) hTERT promotes the invasion of telomerase-negative tumor cells in vitro. Int J Oncol 35: 329-336
65. Liu T, Chung MJ, Ullenbruch M, Yu H, Jin H, Hu B, Choi YY, Ishikawa F, Phan SH, (2007) Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice. J Clin Invest 117: 3800-3809
66. Kunimura C, Kikuchi K, Ahmed N, Shimizu A, Yasumoto S, (1998) Telomerase activity in a specific cell subset co-expressing integrinbeta1/EGFR but not p75NGFR/bcl2/integrin beta4 in normal human epithelial cells. Oncogene 17: 187-197
67. Zhou J, Schmid T, Schnitzer S, Brune B, (2006) Tumor hypoxia and cancer progression. Cancer Lett 237: 10-21
68. Bergers G, Benjamin LE, (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410
69. Ferrara N, Hillan KJ, Gerber HP, Novotny W, (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3: 391-400
70. Avraamides CJ, Garmy-Susini B, Varner JA, (2008) Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 8: 604-617
71. Akiyama SK, Yamada SS, Chen WT, Yamada KM, (1989) Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 109: 863-875
72. Giancotti FG, Ruoslahti E, (1999) Integrin signaling. Science 285: 1028-1032
73. Hynes RO, (2007) Cell-matrix adhesion in vascular development. J Thromb Haemost 5 (Suppl. 1): 32-40
74. Bonanno E, Iurlaro M, Madri JA, Nicosia RF, (2000) Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model. In Vitro Cell Dev Biol Anim 36: 336-340
75. Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE, (2009) Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114: 5091-5101
76. Schor AM, Schor SL, Allen TD, (1983) Effects of culture conditions on the proliferation, morphology and migration of bovine aortic endothelial cells. J Cell Sci 62: 267-285
77. Montesano R, Orci L, Vassalli P, (1983) In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 97: 1648-1652
78. Liu J, Agarwal S, (2010) Mechanical signals activate vascular endothelial growth factor receptor-2 to upregulate endothelial cell proliferation during inflammation. J Immunol 185: 1215-1221
79. Mammoto A, Connor KM, Mammoto T, Yung CW, Huh D, Aderman CM, Mostoslavsky G, Smith LE, Ingber DE, (2009) A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457: 1103-1108
80. Ingber D, Folkman J, (1988) Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59: 44-51
81. Jones RA, Kotsakis P, Johnson TS, Chau DY, Ali S, Melino G, Griffin M, (2006) Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ 13: 1442-1453
82. Nguyen DX, Bos PD, Massague J, (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284
83. Wang Y, McNiven MA, (2012) Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex. J Cell Biol 196: 375-385
84. Beaty BT, Condeelis J, (2014) Digging a little deeper: the stages of invadopodium formation and maturation. Eur J Cell Biol doi: 10.1016/j.ejcb.2014.07.003
85. Parekh A, Ruppender NS, Branch KM, Sewell-Loftin MK, Lin J, Boyer PD, Candiello JE, Merryman WD, Guelcher SA, Weaver AM, (2011) Sensing and modulation of invadopodia across a wide range of rigidities. Biophys J 100: 573-582
86. Parri M, Chiarugi P, (2010) Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 8: 23
87. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ, (2008) Rac activation and inactivation control plasticity of tumor cell movement. Cell 135: 510-523
88. Chen JC, Zhuang S, Nguyen TH, Boss GR, Pilz RB, (2003) Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity. J Biol Chem 278: 2807-2818
89. Xia M, Land H, (2007) Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat Struct Mol Biol 14: 215-223
90. Celià-Terrassa T, Meca-Cortés O, Mateo F, de Paz AM, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A, Guerra-Rebollo M, et al, (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122: 1849-1868
91. Annes JP, Munger JS, Rifkin DB, (2003) Making sense of latent TGFbeta activation. J Cell Sci 116: 217-224
92. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL, (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275: 36803-36810
93. Menon S, Beningo KA, (2011) Cancer cell invasion is enhanced by applied mechanical stimulation. PLoS One 6: e17277
94. Pathak A, Kumar S, (2012) Independent regulation of tumor cell migration by matrix stiffness and confinement. Proc Natl Acad Sci USA 109: 10334-10339
95. Pickup MW, Laklai H, Acerbi I, Owens P, Gorska AE, Chytil A, Aakre M, Weaver VM, Moses HL, (2013) Stromally derived lysyl oxidase promotes metastasis of transforming Growth factor-beta deficient mouse mammary carcinoma. Cancer Res 73: 5336-5346
96. Leight JL, Wozniak MA, Chen S, Lynch ML, Chen CS, (2012) Matrix rigidity regulates a switch between TGF-beta1-induced apoptosis and epithelial-mesenchymal transition. Mol Biol Cell 23: 781-791
97. Bondareva A, Downey CM, Ayres F, Liu W, Boyd SK, Hallgrimsson B, Jirik FR, (2009) The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells. PLoS One 4: e5620
98. Sorokin L, (2010) The impact of the extracellular matrix on inflammation. Nat Rev Immunol 10: 712-723
99. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD, (2006) Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 116: 753-759
100. Meyaard L, (2008) The inhibitory collagen receptor LAIR-1 (CD305). J Leukoc Biol 83: 799-803
101. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ, (2011) Natural innate and adaptive immunity to cancer. Annu Rev Immunol 29: 235-271
102. O'Connor RS, Hao X, Shen K, Bashour K, Akimova T, Hancock WW, Kam LC, Milone MC, (2012) Substrate rigidity regulates human T cell activation and proliferation. J Immunol 189: 1330-1339
103. Israel M, Schwartz L, (2011) The metabolic advantage of tumor cells. Mol Cancer 10: 70
104. Gillies RJ, Robey I, Gatenby RA, (2008) Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49 (Suppl. 2): 24S-42S
105. Vander Heiden MG, Cantley LC, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033
106. Grassian AR, Coloff JL, Brugge JS, (2011) Extracellular matrix regulation of metabolism and implications for tumorigenesis. Cold Spring Harb Symp Quant Biol 76: 313-324
107. Zhang J, Hochwald SN, (2014) The role of FAK in tumor metabolism and therapy. Pharmacol Ther 142: 154-163
108. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, et al, (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64: 3892-3899
109. Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila P, de Paepe A, Tryggvason K, Reeders ST, (1993) Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science 261: 1167-1169
110. Slater SD, McGrath JA, Hobbs C, Eady RA, McKee PH, (1992) Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa. Histopathology 20: 237-241
111. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z, (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98: 137-146
112. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, et al, (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123-127
113. Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R, (2002) Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 83: 111-119
114. Stramer BM, Mori R, Martin P, (2007) The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 127: 1009-1017
115. Dangerfield J, Larbi KY, Huang MT, Dewar A, Nourshargh S, (2002) PECAM-1 (CD31) homophilic interaction up-regulates alpha6beta1 on transmigrated neutrophils in vivo and plays a functional role in the ability of alpha6 integrins to mediate leukocyte migration through the perivascular basement membrane. J Exp Med 196: 1201-1211
116. Franco C, Britto K, Wong E, Hou G, Zhu SN, Chen M, Cybulsky MI, Bendeck MP, (2009) Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis. Circ Res 105: 1141-1148
117. Wesley RB 2nd, Meng X, Godin D, Galis ZS, (1998) Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. Arterioscler Thromb Vasc Biol 18: 432-440
118. Perri RT, Kay NE, McCarthy J, Vessella RL, Jacob HS, Furcht LT, (1982) Fibronectin enhances in vitro monocyte-macrophage-mediated tumoricidal activity. Blood 60: 430-435
119. Stahl M, Schupp J, Jager B, Schmid M, Zissel G, Muller-Quernheim J, Prasse A, (2013) Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation. PLoS One 8: e81382
120. Patel NR, Bole M, Chen C, Hardin CC, Kho AT, Mih J, Deng L, Butler J, Tschumperlin D, Fredberg JJ, et al, (2012) Cell elasticity determines macrophage function. PLoS One 7: e41024
121. Chung A, Cui X, Audeh W, Giuliano A, (2013) Current status of anti-human epidermal growth factor receptor 2 therapies: predicting and overcoming herceptin resistance. Clin Breast Cancer 13: 223-232
122. Zwick E, Bange J, Ullrich A, (2001) Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr Relat Cancer 8: 161-173
123. Waghray M, Yalamanchili M, di Magliano MP, Simeone DM, (2013) Deciphering the role of stroma in pancreatic cancer. Curr Opin Gastroenterol 29: 537-543
124. Liu J, Liao S, Diop-Frimpong B, Chen W, Goel S, Naxerova K, Ancukiewicz M, Boucher Y, Jain RK, Xu L, (2012) TGF-beta blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma. Proc Natl Acad Sci USA 109: 16618-16623
125. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, et al, (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324: 1457-1461
126. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC, (2005) The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat Rev Cancer 5: 505-515
127. Thompson CB, Shepard HM, O'Connor PM, Kadhim S, Jiang P, Osgood RJ, Bookbinder LH, Li X, Sugarman BJ, Connor RJ, et al, (2010) Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models. Mol Cancer Ther 9: 3052-3064
128. Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez HM, Oyasu M, Mikels A, Vaysberg M, Ghermazien H, Wai C, et al, (2010) Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med 16: 1009-1017
129. Golubovskaya VM, (2014) Targeting FAK in human cancer: from finding to first clinical trials. Front Biosci (Landmark Ed) 19: 687-706
130. Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP, Tattersall IW, et al, (2014) Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25: 735-747
131. Meacham CE, Morrison SJ, (2013) Tumour heterogeneity and cancer cell plasticity. Nature 501: 328-337
132. Rombouts K, Carloni V, (2013) The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma. Fibrogenesis Tissue Repair 6: 17
133. Pickup MW, Laklai H, Acerbi I, Owens P, Gorska AE, Chytil A, Aakre M, Weaver VM, Moses HL, (2013) Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-beta-deficient mouse mammary carcinomas. Cancer Res 73: 5336-5346
134. Özdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C, Novitskiy SV, et al, (2014) Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25: 719-734